Concepedia

Irantzu Serrano-Mendioroz

IS

9

Publications

149

Citations

9

H-Index

2015

Active since

Affiliations

Navarre Institute of Health Research(Current)

Clinica Universidad de Navarra

Centro de Investigación Biomédica en Red de Cáncer

Universidad de Navarra

Hospital Universitario 12 De Octubre

Irantzu Serrano-Mendioroz is an author at Navarre Institute of Health Research specializing in medicine, porphyrias, and immunology.

Top concepts

Publications per year

2015–2025

9

Publications

9

Glucose metabolism during fasting is altered in experimental porphobilinogen deaminase deficiency

María Collantes, Irantzu Serrano-Mendioroz, Marina Benito et al. · Human Molecular Genetics · 2016 · 29 citations · Full text

, , +18

Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control

María E. Rodríguez-Ruiz, Irantzu Serrano-Mendioroz, Eneko Garate-Soraluze et al. · Journal for ImmunoTherapy of Cancer · 2023 · 21 citations · Full text

An Inducible Promoter Responsive to Different Porphyrinogenic Stimuli Improves Gene Therapy Vectors for Acute Intermittent Porphyria

Irantzu Serrano-Mendioroz, Ana Sampedro, Manuel Alegre et al. · Human Gene Therapy · 2017 · 20 citations

, , +22

Bioengineered PBGD variant improves the therapeutic index of gene therapy vectors for acute intermittent porphyria

Irantzu Serrano-Mendioroz, Ana Sampedro, Naroa Serna et al. · Human Molecular Genetics · 2018 · 18 citations · Full text

, , +17

Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria

Karol M. Córdoba, Irantzu Serrano-Mendioroz, Daniel Jericó et al. · Science Translational Medicine · 2022 · 15 citations · Full text

Rows per page

1–5 of 9